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We have demonstrated  previously (1)  that  mice infected with  small numbers of 
highly virulent or large numbers of less virulent Cryptococcus neoformans resist chal- 
lenge initiated  14 days later with ordinarily lethal inocula of this pathogen, but not 
with  Staphylococcus  aureus,  Klebsiella  pneumoniae,  or  Mycobacterium  tuberculosis. 
Equal protection was achieved by injection of bacterial endotoxins  1 week prior to 
challenge.  However,  animals  specifically  immunized  with  living  cryptococci were 
able  to  limit  multiplication  during  the  1st  week  of infection,  whereas  those  non- 
specifically  immunized  with  endotoxin  were  not,  although  survival  rates  over  a 
3 month period were similar in both groups. It was also shown that when small num- 
bers of virulent cryptococci were injected intravenously, tissue populations rose in all 
organs studied, including the brain, over the initial 7 days of infection. In some ani- 
mals, progressive disease  ensued leading to death  with hydrocephalus, but the ma- 
jority survived,  and in these,  fungal census fell  gradually,  so that at  the end  of 6 
months, tissues were almost uniformly sterile. 
Additional data gathered on the mechanisms of immunity in specifically and 
non-specifically protected mice challenged  with  C. neoformans form the basis 
for  the  present  report.  Four  aspects  of  experimental  immunity  have  been 
studied: 
1.  The ability of mice surviving infection with small numbers of cryptococci 
to resist ordinarily lethal challenge 3 to 4 months later,  when tissue cryptococcal 
census had  fallen  to virtually zero 
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2.  Tissue populations in control and immunized animals 2 weeks after infec- 
tion with large inocula 
3.  The  possible  correlation  between  protection  and  the  appearance  of 
antibody in the plasma of immunized animals 
4.  Histologic changes  in the tissues  of immune and  control mice 
Materials and Methods 
Mice.--IVIale Swiss albino mice from Carworth Farms, New York (strain CFW) were used 
in all experiments. The animals weighed 16 to 19 gm at the start of immunization and 23 to 
27 gm at the time of challenge. They were housed in metal cages and were given mouse pellets 
and water ad libiturn. 
Cryptococcus S#ains.--These  have  been  described  previously  (1).  Strain  1148,  a  large 
capsule strain, produced  death in 80 to  100 per cent of normal mice within 30 days after 
intravenous injection of 2.5  X  106  cells.  It was  subcultured  on  Sabouraud's  glucose agar 
slants weekly and virulence was maintained by intermittent mouse passage.  Strain B-27,  a 
small  capsule  strain  of  C.  neoforrnans, which  rarely  produced  death  after  intraperitoneal 
inoculation of 5 X  l0  T  cells, was also maintained by weekly subculture on Sabouraud's glucose 
agar. 
Endoto~dn.--Lots AE 1298 $4 and AE 1688 $4 of purified Salmonella endotoxin (pyrexal  ®) 
were employed in these experiments. 
Immunization  Schedule.--Specific immunity was achieved by 3 intraperitoneal injections 
of 2  X  107 cells of strain B-27 at 10-day intervals, the last being administered 2 weeks prior 
to  challenge.  Non-specific immunity was  obtained  by a  single intraperitoneal  injection of 
100 to 200/~g of endotoxin 7 days prior to challenge. 
In additional studies, cells were harvested from a 24 hour Sabouraud's glucose agar slant 
incubated  at  30°C,  suspended  in physiologic saline,  counted  directly in  a  Nenbauer-Levy 
hemocytometer chamber, and diluted to 2 X  103 cells per ml. 0.5 ml of the resulting suspension 
was injected into the lateral tail vein of each mouse. The number of cryptococci in the in- 
oculum was checked by standard  pour plate enumeratlon techniques. 
Challenge Schedules.--Control animals and those immunized with strain B-27,  endotoxin, 
or strain 1148, were always challenged intravenously with  2  X  10  s cells of strain 1148, har- 
vested from a 24 hour Sabouraud's agar slant culture and injected in a 0.50 ml volume into a 
lateral  tail vein.  Groups  of animals were sacrificed at  appropriate  intervals for histologic 
study, determination of circulating antibody, and analysis of tissue populations. Others were 
observed for mortality rates over a  period of 3  months.  Mice immunized intraperitoneally 
with living cryptococci were challenged  14 days after the last immunizing injection. Those 
given endotoxin were infected 7 days later, and animals infected with 103 cells of strain 1148 
intravenously were challenged 1 week, 1 month, 3 months, or 4 months later. 
Tissu~ Population Studies.--Animals were killed by etherization. Lungs, brain,  both kid- 
neys, and the combined fiver and spleen were removed aseptically and were emulsified sepa- 
rately in  2  ml of distilled water with a  teflon tissue  homogenizer.  Sabouraud's  agar pour 
plates were made of serial 100-fold dilutions of the tissue homogenate. Plates were incubated 
at 30°C and colony counts were determined at 2, 4, and 7 days. 
Anti.body DeJerminatlon.--The method used was similar to that described by Neill, Castillo, 
Smith, and Kapros  (2).  Specimens were obtained from normal and immunized mice 2, 4,  7, 
and 14 days after challenge. Groups of 5 mice were lightly anesthetized and were exsangulnated 
through the axlllary artery. Heparinized blood specimens from the 5 animals were pooled and 
the plasma removed and stored at  --20°C until used. In each test, 2-fold saline dilutions of 
each specimen were made. Cryptococcal strains 1148 or B-27 were harvested in saline from a D.  B. LOURIA,  T. KAMINSKI,  AND  G. FINKEL  511 
24 hour Sabouraud's glucose agar slant, killed by heating at 60°C for 1 hour, and diluted to a 
concentration of 2  X  l0  T cells per ml. 0.50  ml of the suspension was added to each plasma 
dilution so that the final volume of the test was 1 ml. The lowest plasma dilution used was 
1: 4. Each specimen was studied with both cryptococeal strains. All tubes were shaken vigor- 
ously manually, incubated at 37°C for 2 hours, and then stored at 4°C. Tubes were read inde- 
pendently by two observers for macroscopic agglutination 1, 2, 4, and 6 days after refrigeration. 
The growth of strain  1148 in control and immunized plasma was also studied at each time 
interval. An inoculum of 10  s cryptococcal ceils suspended  in 0.5  ml of tryptose phosphate 
broth was added to 0.5 ml of each plasma dilution. Tubes were incubated at 37°C, and after 
24 hours, growth was determined by Sabouraud's agar pour plate enumeration techniques. 
Histologic Studiea.--Normal and immunized mice were sacrificed  2, 4, 7, and 14 days after 
challenge. Tissues were placed in formalin and sections of the liver, spleen,  kidneys, lungs, and 
brain were stained with hematoxylin and eosin or by the periodic acid-Schiff method. 
Statistical Analysls.--The  effect of immunization was  studied  by  analyzing cumulative 
mortality curves and 3-month survival in control and immunized groups. The time of deaths 
following challenge was plotted on logarithmic probability paper. The median time of death 
and  significance of protection  were  calculated  according to  the  method  of Litchfield and 
Wilcoxon (3).  Standard  T  tests were used in analyzing tissue populations. The significance 
of survival in immunized animals and controls was compared by the method of chi square. 
EXPEIL[M~NTAL 
1.  Immunity Achieved by Infection with Small Numbers of Virul~t Crypto- 
cocci.-- 
Five separate experiments were performed in which a total of 265 mice were infected with 
10  s cells of strain 1148 intravenously. Fifty of the animals were used  1 week after infection 
either for tissue population studies or for challenge with an ordinarily lethal inocuinm. Of the 
remaining 215 mice, 80  (27 per cent)  died of the infection within 3 months,  the number of 
deaths in individual experiments ranging from 10 to 50 per cent. Tissue cryptococeal  census 
was determined in 35 survivors 1 to 6 months after inoculation, and an additional 93 animals 
were challenged intravenously with 2.5 X  10  e cells of virulent strain 1148. 
Three challenge experiments were performed at 1 week after infection with 10  s cells, 3 at 
1 month, 3 at 3 months, and  1 at 4 months. On each occasion, 10 control mice of the same 
age and approximately the same weight were challenged simultaneously. 
The results of tissue population studies are depicted in Text-fig. 1. Crypto- 
coccal census rose in all tissues studied during the initial 7 to 28 days, increase 
being maximum in the brain. In the 15 animals observed 3 months, and the 
5  studied 6  months after infection, fungus populations fell markedly. In  12 
of the 20 animals, all tissues studied were either sterile or contained less then 
2.5 X  101 cryptococci and in 7 of the remaining 8 animals, only a single tissue 
had a  fungal census of greater than 102, large numbers of cryptococci being 
recovered from the 20th animal. 
No protection was observed in any of the 3 experiments in which mice were 
challenged with a  lethal inoculum 1 week after infection with 103 cells intra- 
venously. Similarly, no protection was observed in 1 of the 3 challenge experi- 
ments performed  1 month after inoculation with  10  s cells,  but in  the other 512 
LOG NO.  CRYPTOCOCCI  PER  ORGAN 
NO  CULTURABLE  CRYPTOCOCCI 
IMMUNITY IN  CRYPTOCOCCOSIS 
O  LIVER-SPLEEN  A  BRAIN  •  KIDNEYS  •  LUNGS 
AA 
•  A  A~AA 
oO  oAA  -  l 
o o  •  A  ~..~  ,o&~  , 
DO  o • O/l/l&~'l 0  • 
•  l  A  I  ~o~'.  .q~ ~ ,~o-.~ 
°..,  I  - 
....  I  ........  I  -°°  ......  ,' 
O 
A 
Oo 
A 
O  ooO A~A  A 
•  A  tA 
~  ,~-.-~-~-~ i 
~""  Zl  aA  ~oOOA  A A& 
A 
o  ~ 
oo:e~ 
I  7  28  90  180 
DAYS AFTER INFECTION 
TExT-FIG. 1. Cryptococcal populations  in mouse tissues following intravenous  infection 
with 103 cells of C. neoJormans, strain  1148. 
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TExT-Fro. 2. Mortality in mice infected intravenously with 2.5 X 106 cells of C. neoformans, 
strain  1148, 1 month after intravenous infection with 10  a cells of the same strain. 
2 experiments, death was delayed and 3 month survival significantly increased 
(P  <  0.01);  all  18  control mice  died  within  the  study period,  whereas  9  of 
18 (50 per cent) of the immunized animals survived. One of the 2 experiments 
in which protection was observed is shown in Text-fig.  2. Delay in death  and 
increased  survival  were  observed  in  all  5  experiments  performed  at  the  3  to 
4  month interval; 30 of 65  (42.2 per cent) of immunized animals survived the D.  B. LOURIA,  T. KAMINSKI,  AND  G. ]~INKEL  513 
3 month challenge period, whereas all 47 controls died. One of these studies is 
depicted in Text-fig. 3  and all  11  challenge experiments are  summarized in 
Table I. 
2.  Two-Week Tissue Population Studies.--Because mice previously exposed 
to  cryptococci showed limited multiplication of the  fungus during the  first 
7  days  after  challenge,  and  those  immunized with  endotoxin did  not  (1), 
it  seemed  important  to  determine  whether  endotoxin-protected  animals 
survived despite high tissue populations or whether they gained control of the 
infection between the 7th and 14th day, a period during which control animals 
began to  die with hydrocephalus. In 2  experiments, groups  of 5  mice were 
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TExT-FIG. 3. Mortality in mice  infected  intravenously  with 2.5 X 106 ceils  of C. neoformans, 
strain 1148, 3 months after intravenous infection  with 108 cells of the same strain. 
sacrificed for determination of brain fungus census  1,  7,  and  14  days after 
infection. These studies are summarized in Text-fig. 4. Progressive multiplica- 
tion was observed in control animals over the 14 day period. In mice immunized 
with  strain  B-27,  cryptococcal  multiplication  was  considerably  reduced, 
populations averaging 1 log unit less than those found in controls at both the 
1 and 2  week intervals.  These differences are  statistically highly significant 
(P  <  0.01).  In endotoxin-treated animals, brain populations at the end of 7 
days were indistinguishable from those of the controls, but 1 week later,  (14 
days after infection), brain census was similar to that observed in specifically 
immunized mice and differed from controls by more than 1 log unit, a difference 
with high statistical significance (P  <  0.01).  Thus, the endotoxin-immunized 
animals appeared  to  gain control of the  infection between the  1st  and  2nd 
week after challenge. 514  TM~UNITY  IN  CRYPTOCOCCOSIS 
3.  Antibody and Plasma Inhibition Studies.--Since endotoxin-treated animals 
showed no ability to limit the infection during the 1st week, but gained control 
thereafter, it seemed possible that this phenomenon might be associated with 
the  appearance  of circulating antibody.  Plasma  was  studied  from the  same 
animals whose tissue populations are depicted in Text-fig. 4.  The results are 
shown in Table II. No agglutinating antibody was demonstrable in the plasma 
TABLE I 
Mortality in Mice Infected Intravenously with 2.5 X  10* Cells of C. neoformans Strain 1148 at 
Various Times after Intravenous Infection  with 103 Cells of the Same Strain 
Time of challenge 
1 wk. 
1 mo. 
3 mos. 
Experiment 
No. 
7 
8 
9 
10 
LDso 
Control  Immunized  Control 
days 
2O 
16 
5 
days 
22 
17 
5 
55 
>90 
40 
71 
>90 
53 
80 
1/10 
O/lO 
o/9 
3/10 
0/8 
0/10 
O/lO 
0/10 
O/lO 
0/10 
50 
5 
14 
20 
4 
9 
18 
3 too.  Survivors 
Immunized 
O/lO 
0/10 
0/9 
3/10 
S/8 
4/10 
5/10 
7/lO 
4/10 
11/2S 
4 mos.  11  10  62  0/7  3/7 
Survivors, experiments  5 to 11 ........................  0/65  39/83 
(47 per cent) 
of normal mice at 2, 4, 7, or  14 days using either strain 1148 or B-27 as the 
antigen.  Agglutinating  antibody titers of  1:4 to  1:8 were found in  1 of the 
2 plasma specimens of specifically immunized mice studied 4 days and in 1 of 
the 2 specimens obtained 2 weeks after challenge. Both the 2 day and 7 day 
specimens showed no agglutination on repeated  testing with both  strains  of 
C. neoformans.  Thus, between the 4th and 14th day, 2 of 6 specimens studied 
showed low agglutination titers. The findings in the endotoxin-treated animals 
were in striking contrast to those in the normal and specifically immunized. 
No agglutination was observed in  the 2  and  4  day specimens, but in  the  1 
week plasmas,  titers varied from 1:8 to 1:16 with strain B-27 as the antigen, 
and from 1:16 to  1:32  with  homologous strain  1148  as  the  antigen.  At the 
2 week interval, titers varied from 1:4 to 1:8 with both antigens. D.  B.  LOURIA,  T.  KAMINSKI~  AND  G.  ;FIIN'KEL  515 
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TEXT-FIG.  4. Brain cryptococcal  populations in specifically  and non-specifically  (endotoxin) 
immunized mice 7  and  14 days after intravenous  challenge with 2.5  X  10' cells of C.  neo- 
formans,  strain 1148. 
TABLE II 
Agglutinating Antibody Titers in Plasma of Mice Immunized  Specifically and Non-Specifically 
l~ndotoxin) against C. neoformans 
Days after challenge with  2  4  7  14 
strain 1148  .................... 
Exp. No. 
1  Specifically  im-  <1:4  <1:4  <1:4  <1:4 
2  munized*  1:4  to  1:8  1:4  to  1:8 
1  Endotoxin-trcated  1:8  to  1:32  1:4  to  1:8 
2  <1:4  <1:4  1:8  to  1:32  1:4  to  1:8 
1  Control 
<1:4  <1:4  <1:4  <1:4  2 
* Results with antigens B-27 and 1148 were similar and are pooled. 
When  1@ cryptococci were added to  1:4 or  1:8 dilutions  of normal mouse 
plasma, populations  increased  1000-fold in 24  hours.  Plasmas obtained from 
specifically immunized  and  endotoxin-immunized  animals 2  to  14 days after 
challenge showed no evidence of ability to limit cryptococcal growth. 516  IM]~UNITY IN CRYPTOCOCCOSIS 
4.  Histopathology of Cryptococcu3 Infection.- 
Central nervous system infection with C. neoformans  was characterized by numerous focal 
lesions scattered  diffusely throughout  the brain  (Fig.  1).  Organisms were usually but  not 
invariably present in these areas. Although cryptococci could be demonstrated  by the usual 
hematoxylin and  eosin stain,  they were more consistently visualized by the periodic acid- 
Schiff stain. A remarkable feature of these lesions in control animals (including those sacrificed 
at 2 weeks)  was the paucity of the inflammatory reaction; neither cellular infiltration, glial 
response,  nor neuronal change could be found, even within and surrounding large or confluent 
areas of cryptococcal invasion. In both immunized groups, the lesions were equally bland in 
specimens obtained 2 days and 4 days after infection. At 1 week, however, a  definite and 
occasionally very prominent inflammatory response could be detected, the exudate consisting 
of a  mixture of neutrophils and mononuclear cells (Fig.  2).  Cellular response in specifically 
immunized and in endotoxin-immunized mice showed no differences. 
The meninges were also involved by infiltration of acute and chronic inflammatory cells 
into the leptomeninges. The inflammatory reaction began  early and  was progressive. The 
treated and control groups did not differ (Fig. 3). 
A focal vascular inflammatory response was elicited at the 1 and 2 week intervals in both 
control and immunized groups, but was more frequent and more severe in the latter (Fig. 4). 
The lesions were thought to be focal endothelial proliferations, but infiltration by mononuclear 
cells could not be ruled out. Infrequently, neutrophils were present, but again it was sometimes 
difficult to decide whether these were within the lumen or the wall of the vessel. 
Microscopic sections of heart, lung, liver, spleen,  and  kidneys were also examined. Orga- 
nisms were not seen in the spleen,  but infected animals showed reactive hyperplasia of the 
lymphoid follicles.  In the other organs, cryptococci could be found and frequently elicited a 
focal inflammatory reaction consisting of a mixture of polymorphonuclear leukocytes, lympho- 
cytes, and hisfiocytes. Unlike the situation in the central nervous system, no difference in the 
extent of the lesions or in the cellular responses could be detected at any of the time intervals 
studied.  Lesions  containing  the  organism  but  with little inflammatory  response  were oc- 
casionally found in control and treated groups infected for 2 weeks, as were hepatic granulomas 
devoid of organisms. 
DISCUSSION 
It  has  long  been  held  that  host  cellular  and  antibody  defense  mechanisms  are 
inadequate  in  cryptococcosis.  This  has  been  based  on  the  histologic  observations 
of myriads  of cryptococci in  tissues  of both  animals and  man in  the absence of an 
inflammatory response, and o n past failures to demonstrate immunity in experimental 
animals or circulating antibody in the serum of man during the course of cryptococcal 
infection. Studies from several laboratories have indicated that this thesis is no longer 
tenable.  We  have  demonstrated  previously  that  infection  with  small  numbers  of 
highly virulent cryptococci or large numbers of less virulent strains intraperitoneally 
protects animals against intravenous challenge 2 weeks later (1).  In the experiments 
reported herein, we have shown that death is delayed and survival markedly increased 
if mice are challenged 1 to 4 months after infection with  10  s cells of a  virulent strain 
intravenously,  protection  being consistently observed even when tissue cryptococcal 
census  is extremely small.  In addition,  Gadebusch  (4)  successfully immunized mice 
with  purified  cryptoeoccal  capsular  polysaccharide  plus  adjuvant.  Abrahams  and 
Gilleran  (5)  found  increased  resistance  following  vaccination  with  suspensions  of D.  B.  LOURIA~  T.  KAMINSKI,  AND  G.  ]~INKEL  517 
formalin-killed cells. In their studies, in contrast to the prolonged immunity noted in 
our experiments, the induced protection was short-lived and resistance was significantly 
decreased when challenge was made 21 instead of 14 days after immunization. Vogel, 
Sellers, and Woodward (6), using fluorescent techniques, have demonstrated antibody 
in the serum of patients with cryptococcosis, as have Pollock and Ward (7) utilizing a 
hemagglutination test, and Bennett, Tynes, and Hasenclever employing complement- 
fixation  techniques  (8). It would appear,  then, that antibodies  are  formed against 
invading cryptococci,  and that at least under certain  experimental  circumstances, 
immune mechanisms  may be quite effective in limiting progressive multiplication  of 
the fungus. 
Gadebusch, and Abrahams and Gilleran, demonstrated diminished protection when 
large amounts of vaccine or purified capsular polysaccharide were used, thus support- 
ing the contention of Salvin  (9)  that the failure  to demonstrate  a  brisk  antibody 
response may be  related  to paralysis  of immune  mechanisms induced  by antigen 
excess, 
The current experiments and those previously reported from this laboratory 
suggest  that  this  is  probably  of  small  clinical  significance.  Multiplication 
occurred in all tissues for a period of 1 week to 1 month after inoculation with 
small nurnhers of cryptococci but thereafter, the majority of animals gained 
control of the infection. Since the greatest amount of circulating polysaccharide 
antigens should be expected when tissue populations are maximum, it is dif- 
ficult to explain the ability of the mouse to gain control of the infection at this 
time if one accepts  the  thesis that immune paralysis due  to  antigen excess 
plays any significant role in the course of cryptococcosis. More likely, past 
failure to demonstrate circulating antibodies has been due to the use of tech- 
niques which were not sensitive enough to detect them. Recent advances in 
methodology (6-8)  may  now  permit  demonstration  of  significant  titers  of 
circulating  antibody in  the  majority of patients  and  experimental  animals 
with cryptococcosis. 
It is interesting that agglutinating antibody was present more consistently 
and in higher titer in endotoxin-pretreated animals than in those specifically 
immunized. Although administration of endotoxin is known to increase anti- 
body response (10),  it also modifies many other host defense mechanisms, and 
this may result in increased resistance to homologous or heterologous infections. 
These alterations include increased phagocytic capacity of the reticuloendo- 
thelial system (11), augmented leukocyte response (12), enhanced phagocytosis 
by polymorphonuclear leukocytes (13),  release  of preformed antibody  (14), 
increase in plasma bactericidins (15),  and enhanced ability to resist the lethal 
effects of microbial toxins (16).  In the present studies, however, only the aug- 
mented ability to form antibody appears important. There was no change in 
the distribution of microorganisms or their initial growth over the first 7 days, 
and such change would have occurred if reticuloendothelial activity or plasma 518  IMMUNITY  IN CRYPTOCOCCOSIS 
fungicidal substances had been significantly altered. An increased polymorpho- 
nuclear leukocyte response was seen in histologic sections 7 days after infection, 
but there was no evidence of control of the infection in endotoxin-treated mice 
during this period. Conversely, specifically immunized mice, which showed an 
identical cellular response, did limit cryptococcal growth during the initial 7 
days. Failure to demonstrate antibody 2 and 4 days after challenge indicates 
that the release of preformed antibody also played no role in these experiments. 
The  significant difference in  tissue  census between  controls  and  endotoxin- 
treated animals 2 weeks after challenge (when control animals began to die) 
suggests strongly that the major factor in increased survival was limitation of 
microbial multiplication rather than an ability to resist microbial toxins. Salvin 
has performed studies suggesting that cryptococci may contain endotoxin-like 
material (17), but there is no conclusive evidence that death in cryptococcosis 
is related either to an exotoxin or to cryptococcal endotoxins. 
Although the importance of immune mechanisms in control of cryptococcosis 
appears clear, it is not known whether limitation of cryptococcal multiplication 
is related to circulating antibody, tissue-bound antibody, or alterations in host 
cellular defenses. As noted above, tissue cryptococcal populations could not be 
correlated with the enhanced cellular response observed  in both specifically 
protected and endotoxin-treated animals. Gadebusch was able to delay death 
in mice infected with C. neoformans by treatment with immune rabbit serum 
(18). Since cryptococci and serum were injected intraperitoneally within 2 hours 
of each other, the resulting intraperitoneal agglutination may have reduced the 
size  of the inoculum, a  possibility which makes interpretation of the results 
difficult. In the present experiments, endotoxin-treated mice inhibited fungus 
growth only after circulating antibody could be readily demonstrated. However, 
specifically immunized animals were able to limit cryptococcal multiplication 
during the initial 7 days of infection despite low circulating antibody titers. 
Since control of the infection could not be closely related to either circulating 
antibody or the augmented cellular infiltration, it would seem reasonable to 
attribute inhibition of fungal growth to the presence of tissue-bound antibody. 
Our findings do not derogate the importance of the initial sparse inflammatory 
response which may permit early dissemination to distant sites shortly after the 
establishment of a  focal lesion. Indeed, it would appear  to be  a  reasonable 
hypothesis that strongly encapsulated cryptococci both fail to elicit and also 
resist host cellular defenses until antibody is present, at which time the pro- 
duction of capsular material is  reduced or capsular substances diffuse away 
from the cell  wall,  thus permitting phagocytosis by host defense cells.  This 
concept is consistent with the studies of Gadebusch, who showed that large 
capsule strains of C. neoformans are not phagocytosed by polymorphonuclear 
leukocytes whereas small capsule strains are (18), and with the experiments of 
Iverson and Kase (19), who demonstrated that in older lesions, the fungus cells D,  B.  LOURIA,  T.  KAM~_NSKI~ AND  G.  FINKEL  519 
appear to have less capsular material surrounding them and are phagocytosed 
by large mononuclear cells. 
Since host immune mechanisms can be effective in cryptococcosis, it seems 
likely that this disease is far more common than has been heretofore recognized. 
It is indeed possible that in man, cryptococcosis, much like histoplasmosis, is 
usually a short-lived, benign illness limited to the lungs which only infrequently 
progresses  to  severe  dissemination.  The  apparent  dependence  on  immune 
mechanisms also lends further weight to the contention that the susceptibility 
of some patients with reticuloendothelial disease to torulosis is related to their 
well documented inability to respond adequately to certain antigens rather than 
to any change in the tissue biochemical m///eu which might provide additional 
growth factors for invading cryptococci. 
SUMMA.RY 
Following infection with  I0  3 ceils  of Cryptococcus neoformans,  progressive 
multiplication occurred in all tissues for 7 to 28 days. Thereafter, most mice 
gained control of the infection so that 3 to 6 months after inoculation, tissues 
were usually sterile or contained only small numbers of cryptococci. Survivors 
challenged 1 to 4 months after infection with 10  a cells lived longer than controls 
and had an increased survival rate. Pretreatment with bacterial endotoxin also 
resulted in protection against cryptococcal challenge. Endotoxin-protected ani- 
mals showed no ability to limit the infection until circulating antibody could be 
demonstrated. 
Histologic studies revealed an increased cellular infiltration in the brains of 
specifically protected and endotoxin-protected mice 1 to 2 weeks after challenge. 
However, control of cryptococcal multiplication could be correlated with the 
presence of antibody but could not be correlated with the enhanced cellular 
response. 
Although protection against cryptococcal challenge appears to be antibody- 
dependent, it is unclear whether protective antibody is to be found in plasma 
or is tissue-bound. 
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EXPLANATION OF PLATES 
PLATE 20 
FIO. 1.  Bland cyst-like lesion in brain of control animal 2 weeks after inoculation. 
Hematoxylin and eosin. ×  150. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL.  117  PLATE  20 
(Louria  a  a/.:  Immunity  in  cryptococcosis) PLATE 21 
FIG. 2.  Brain abscess containing inflammatory cells and cryptococcus organisms in 
immunized animal 2 weeks after inoculation. Hematoxylin and  eosin.  ×  500. THE  JOURNAL  OF  EXPERIMENTAL MEDICINE  VOL. 117  PLAT~ 21 
(Louria  et  al.:  Immunity  in  cryptococcosis) PLATE 22 
FIO.  3.  Cryptococcal meningitis in  immunized  animal  1 week  after inoculation. 
Hematoxylin and  eosin.  ×  500. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL.  117  PLATE  22 
(Louria  et  al.:  Immunity  in  cryptococcosis) PLATE 23 
FIG. 4.  Focal endothelial proliferation in small cerebral vessel of immunized animal 
2 weeks after inoculation. Hematoxylin and eosin.  X 500. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL.  117  PLATE  23 
(Louria  eta/:  Immunity  in  cryptococcosis) 